Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MAGNESIUM OXIDE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources
PubMedDate not supplied

Release of albumin from oligoester plastic matrices: effect of magnesium oxide and bivalent stearates.

Biodegradable implantable matrices containing bovine serum albumin were prepared from oligoesters by melting, and subsequently tested on in vitro albumin release. The linear poly (DL-lactic acid) and the branched terpolymer of DL-lactic acid, glycolic acid, and mannitol were synthesized. Products were of similar molecular weight and possessed different thermal and swelling characteristics. Oligoesters were loaded with 4% albumin and plasticized by 30% triacetin. Other additives added into the matrices as albumin stabilizers were divalent stearates and magnesium oxide. The influences of oligomer molecules constitution, divalent ion stearates or magnesium oxide addition, and triacetin concentration on the albumin release were quantified. SDS-PAGE revealed protein hydrolysis during the dissolution tests.

Albumins↗
PubMed2003

Novel halogen and interhalogen adducts of nanoscale magnesium oxide.

The difference in the adsorption properties of magnesium oxide in two different physical forms--large micron-sized crystals (CM-MgO) and nanoscale crystals (AP-MgO)--is described. The highly energetic surface of the nanoparticles is significantly more active than the bulk surface in adsorption of nonpolar halogens (Cl(2), Br(2), and I(2)) and dipole interhalogen molecules (ICl, IBr, and ICl(3)). The nanocrystalline and microcrystalline MgO adducts with halogens and interhalogens were characterized by thermogravimetric analysis (TGA), UV-vis and Raman spectroscopies, and transmission electron microscopy (TEM). The bonds of the adsorbates were considerably strained upon adsorption on the nanocrystalline MgO without a molecular dissociation. The results presented in the paper explain the enhanced reactivities of the nanoscale MgO, halogen adducts as halogenating agents of organic molecules and their noticeable biocidal activity.

Journal Article↗
PubMedDate not supplied

[Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].

The study aimed at presenting own experience in prevention of new urinary calculi in 18 patients with metabolically active calcium urolithiasis treated with hydrochlorothiazide in daily doses of 100 mg (group I) for 2 years, and in 6 patients with the same disease treated with magnesium oxide in daily doses 300 mg twice a day (group II) for average period of 10 months. In 9 patients a new calculus was formed during the treatment with hydrochlorothiazide, in 7 patients no recurrence was noted, and in 2 remaining patients the results were controversial (coral calculus). Therefore, patients were subdivided into group Ia (failure of hydrochlorothiazide therapy), and group Ib (no recurrence noted). Hydrochlorothiazide did not lead to the stable decrease in the saturation of the urine with calcium oxalate in group Ia whereas in group Ib (without recurrence of urolithiasis) the content of calcium oxalate in the urine was significantly lower than that in group Ia after a 2-year treatment with hydrochlorothiazide (p < 0.01) Recurrence of the disease was seen only in one patient of group II, i.e. treated with magnesium oxide. The treatment of the recurrent calcium urolithiasis is justified and efficient in those patients in whom therapy decreases the content of calcium oxalate in the urine.

Adult↗
PubMed1980

Influence of the sterilization method and of magnesium oxide on the tissue responses in the rat to modified starch glove powders.

The tissue response to samples of a surgical glove powder was assessed from counts of the adhesions and granulomas found 7 and 14 days after introduction into the peritoneal cavity of rats, and by a histological study of affected tissues. Negative control groups treated with no powder and positive controls treated with talc were included. Various sample treatments were implemented to examine the effect of the sterilization method on the tissue response and the influence of magnesium oxide, normally added as a dispersing agent. The glove powder produced less reaction when steam-sterilized than when gamma-irradiated and the presence of magnesium oxide at 2% concentration made no detectable difference.

Animals↗
PubMedDate not supplied

Effect of dolomite, magnesium oxide (MgO) and chalk (CaCO3) on in vitro fermentation of amorphous and crystalline cellulose and meadow hay using inoculum from sheep.

Some minerals can influence some biochemical parameters of rumen fermentation. The objective of this experiment was to determine the effect of different amounts (0.1, 0.25 and 0.5 g) of dolomite and to compare the effect of dolomite, magnesium oxide (MgO) and chalk (CaCO3) upon the end products of rumen fermentation in vitro. Amorphous and crystalline cellulose as well as meadow hay were used as substrates and incubated with buffered rumen fluid in sealed fermentation bottles. In dependence on the amount of dolomite and the kind of substrate an inhibitory effect of dolomite on methane production was evident. Significant differences of methane production were found between the controls, crystalline cellulose and meadow hay with 0.5 g of dolomite. An increase of total gas production was observed for cellulose with both 0.25 and 0.5 g of dolomite and also for meadow hay with 0.5 g of dolomite. It can be concluded that there was a remarkable effect of dolomite on methane production and also a slight effect of magnesium oxide and chalk as compared to the effect of dolomite on the fermentation parameters of incubated substrates.

Animal Feed↗
PubMed1994

Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.

A combined supplement of magnesium oxide (300 mg/day) and pyridoxine.HCl (10 mg/day) was given p.o. to 16 recurrent calcium oxalate (CaOx) stone formers, and its therapeutic efficacy was biochemically evaluated by measuring various parameters of blood (Na, K, Mg, urea, creatinine, calcium, phosphate, uric acid, alanine transaminase, aspartate transaminase and alkaline phosphatase) and urine (volume, pH, creatinine, Na, K, Mg, uric acid, calcium, phosphate, oxalate and citrate) at 0, 30, 60, 90 and 120 days of treatment. Serum Mg significantly (P < 0.01) increased after 30 days of treatment and remained constant thereafter while other blood parameters were unaltered. Combined treatment led to a significant increase in the urinary excretion of Mg and citrate over pretreatment values while oxalate excretion showed a gradual and significant decline during the therapy. The results confirmed the efficacy of MgO-pyridoxine supplementation in terms of changes in urinary excretion of lithogenic and inhibitory components, leading to a significant (P < 0.01) decrease in CaOx risk index from 0.09 +/- 0.04 at 0 day to 0.05 +/- 0.02 after 120 days of treatment.

Adult↗
PubMed2005

[The quality evaluation of magnesium oxide tablet due to acid neutralization action].

For the purpose of quality evaluation of magnesium oxide (MgO) tablets, we considered the dissolution test method with changes in the pH of the dissolution medium as an indicator and studied the elution behavior of MgO from commercial MgO tablets. We also studied the effects of particle size on the elution rate of MgO from MgO tablets. A dissolution test was carried out using the rotating basket method in 100 ml of the first fluid (pH 1.2). The stirring speed was set at 200 rpm. The elution behaviors of MgO from two products were markedly different. The medium pH for the sample MM (Magmit) tablet after 15 min reached 9.5 but that for ML (Maglax) tablet was 2.7 even after 60 min. The apparent solubility of MgO in 100 ml of the first fluid were, respectively, 175 mg and 100 mg when medium pH as 9.5 and 1.5. The low dissolution of ML tablets is thought to be due to the large particle size (average particle size r = 226 microm) or due to the effects of additives on elution. These results suggest that neutralizing activity after ingestion of MgO tablets and subsequent laxative effects may, when conditions after ingestion of MM tablets and after ingestion of ML tablets are compared, produce differences between them. We found that the dissolution test method with pH as an indicator is useful in assessing the dissolution behavior of MgO preparations.

Cathartics↗
PubMed1985

Metabolic alkalosis with hypertonic dehydration in a patient with diarrhoea and magnesium oxide ingestion.

An eight-week-old infant with diarrhoea and dehydration became markedly alkalotic after administration of magnesium oxide powder. The literature does not substantiate the premise that significant magnesium deficiency may occur during acute gastroenteritis in an otherwise healthy infant. Physicians should be warned about this form of therapy as a possible cause of metabolic alkalosis. The possibility of congenital alkalosis with diarrhoea should be considered in differential diagnosis.

Alkalosis↗
PubMed1984

Biochemical effects in patients with calcium oxalate stone disease during combined treatment with bendroflumethiazide and magnesium oxide.

Thirteen patients with calcium oxalate stone disease were treated with 2.5 mg bendroflumethiazide and 200 mg magnesium oxide twice daily for 1 year, and the effects on serum and urine constituents were evaluated. Serum magnesium and potassium decreased, whereas urate increased during treatment. The association of decreased urinary calcium and increased urinary magnesium resulted in a reduced Ca/Mg quotient and apparently a lower risk of forming urine supersaturated with calcium oxalate. Combined treatment with a thiazide and magnesium appears to alter the composition of urine in a way that might be more favourable than treatment with either substance alone.

Adult↗
PubMed2004

Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.

OBJECTIVES: To examine urinary parameters among normal individuals and patients with calcium oxalate (CaOx) stones after oral administration of potassium-sodium citrate (KNa-Cit) and magnesium oxide (MgO). Urinary citrate and magnesium have been known as the inhibitors of CaOx stone formation. Supplementation with potassium-magnesium citrate prevents the recurrence of CaOx stones. METHODS: Twenty-five male volunteers aged 21 to 42 years without a history of urinary stones were given either KNa-Cit or MgO, or both. Fourteen patients with recurrent CaOx stones were also given both supplements, and 24-hour urine samples were collected to determine the urinary parameters. RESULTS: The administration of both KNa-Cit and MgO to the normal individuals increased the excretion of citrate, magnesium, and potassium by 70.0%, 44.2%, and 50.0%, respectively. These parameters increased less when KNa-Cit or MgO was administered individually. After administration of both supplements to the patients with stones, the citrate, magnesium, and potassium levels increased by 62.1%, 63.3%, and 25.3%, respectively, and oxalate decreased by 66.5%. In both normal individuals and patients, the ion activity product index of CaOx decreased significantly more after administration of the combination than with either compound alone or before administration. CONCLUSION: The combination of KNa-Cit and MgO is more effective than either supplement alone in inhibiting the crystallization of CaOx stones. The combination may improve the urinary parameters of patients with stones accompanied by hypocitraturia and/or hypomagnesuria.

Administration, Oral↗
PubMed2006

First principles density functional study of the adsorption and dissociation of carbonyl compounds on magnesium oxide nanosurfaces.

The adsorption and dissociation of three carbonyl compounds, formaldehyde, acetaldehyde, and acetone, on the magnesium oxide nanosurface, consisting of four stacked (MgO)3 hexagons, is investigated by first principles density functional theory (DFT). In the case of formaldehyde, strongly chemisorbed species, with carboxylate-like structures, are initially formed. These may subsequently undergo heterolytic cleavage of an aldehyde C-H bond to form formate ions involving a surface oxide ion and a hydride ion adsorbed over the magnesium dication [(MgH+)(HCOO-)]. For acetaldehyde, besides this reaction leading to the formation of acetate, the methyl hydrogen of the adsorbed species also tends to attach itself to a surface oxide ion, yielding surface hydroxyl ions and adsorbed [CH2=C(H)OMg]+. These results are in accord with our previous experimental and theoretical results. In particular, the shift of the aldehyde C-H vibration band to higher frequency and the appearance of OH bands in the infrared spectrum are clearly accounted for. For acetone, the mechanism is found to be similar, i.e., a methyl hydrogen shift to yield surface enolate. Again, this is in agreement with experimental studies.

Journal Article↗
PubMed1989

Effect of dietary sodium bicarbonate and magnesium oxide on cows with milk fat depression in several dairy herds.

Buffer mainly consisting of 100 g of sodium bicarbonate and 30 g of magnesium oxide was added to the feed per head per day and given for 8 months to groups of 92 cows of milk fat depression. Milk fat increased from 3.06% (pre-treatment) to 3.68% at 4 months and 3.71% at 8 months post-treatment. Solids-not-fat was slightly increased by the buffers. Milk production was not affected. The number of rumen protozoa increased from 2.85 X 10(5)/ml (pre-treatment) to 9.61 X 10(5)/ml at 8 months post-treatment and the kinds of protozoa diversified. An increase of acetate and decrease of propionate were observed together with increased milk fat at 8 months post-treatment. An increase of hematocrit, lactate dehydrogenase, sodium and potassium, and a decrease of cholesterol and gamma-glutamyl transpeptidase in blood were recognized after the treatment. The incidence of disease was reduced. There was a significant correlation between increased milk fat percentage and increase in the number and the kinds of protozoa.

Animals↗
PubMed1975

Magnesium oxide as carrier dust in benzo(a)pyrene-induced lung carcino-genesis in Syrian hamsters.

The neoplastic progression induced by intratracheal instillation of benzo[a]pyrene (BP) and magnesium oxide (MgO) was compared with that induced by intratracheal instillation of BP and ferric oxide (Fe2O3). BP and MgO produced squamous cell carcinomas and papillomas in the larynx with a latent period as shor as 9 weeks. They also induced many papillomas as well as squamous cell carcinomas and adenocarcinomas in the trachea and a papilloma, squamous cell carcinomas, adenocarcinomas, adenosquamous lesions, and peripheral adenomatoid lesions in the bronchi. They rarely caused tumors in other organs; only a few forestomach papillomas, one melanoma on the dorsal skin, and one ovarian carconoma were seen BP, with Fe2O3 as the carrier, induced a comparable number of histologically similar tumors; however, tumors developed more frequently in the main bronchi. Thus MgO strongly facilitated the tumor-inducing effects of BP, causing tumors in different areas of the respiratory tract, and was as effective as Fe2O3 as a carrier agent in the experimental induction of respiratory tumors.

Animals↗
PubMed1986

Effects of sodium bicarbonate, magnesium oxide, and a commercial buffer mixture in early lactation cows fed hay crop silage.

Sixteen early lactation Holstein cows fed 70% concentrate: 30% hay crop silage were used to determine effects of .7% sodium bicarbonate, .7% sodium bicarbonate plus .28% magnesium oxide, or 1.8% commercial buffer mixture (total ration dry basis). This mixture contained a variety of buffers, alkalis, and other compounds known to affect milk production or composition in some circumstances. Buffers did not affect dry matter intake, milk yield, or milk composition but decreased efficiency of milk production. Ruminal fluid pH was not affected, but fecal pH and digestibilities of dry matter, organic matter, energy, acid detergent fiber, and cellulose were increased by the mixed buffers compared with sodium bicarbonate alone. Total ruminal volatile fatty acid concentration was reduced by buffers. Compared with sodium bicarbonate alone, mixed buffers increased ruminal ammonia concentration, acetate proportion, and acetate:propionate ratio and decreased proportions of propionate and butyrate. Valerate was reduced by all three buffers. Ruminal volume and liquid dilution rate were unaffected, but buffers increased total fluid outflow from the rumen. Higher amounts of buffers or alkalis may be necessary to offset low rumen pH and affect production with hay crop silage-based diets.

Animal Feed↗
PubMedDate not supplied

Low milk fat syndrome and magnesium oxide supplementation.

The low milk fat syndrome most commonly occurs in dairy cows fed diets with a high ratio of carbohydrate to roughage. It is characterized by markedly depressed yields of milk fat. Rumen buffers, such as sodium bicarbonate (NaHCO3) and magnesium oxide (MgO), are known to correct the milk fat depression observed on restricted roughage rations, although by apparently different mechanisms. The mode of action of NaHCO3 can be explained by control of the proportion of ruminal propionate via control of rumen pH. Cows fed diets supplement with NaHCO3 showed increased feed intake and improved digestibility of dry matter or fibre. The mechanism by which Mg increases milk fat concentration may operate at both rumen and tissue level. Most studies with MgO have suggested that it acts as a buffer or neutralizer in either the rumen or the intestine. During digestion, the addition of MgO increases digestibility of dry matter, as does NaHCO3. Among many different tissue effects, MgO supplementation increases triglyceride uptake by the mammary gland. Feeding MgO tends to increase lipoprotein lipase activity in the mammary gland and to decrease the linoleic acid content of milk fat. The percentage uptake of triglycerides from lipoproteins and milk fat by the mammary gland was greater in cows fed MgO-supplemented rations than in cows fed restricted roughage rations. Triglyceride-rich lipoprotein concentrations are uniquely low in cow plasma compared to other species, but still account for a major portion of the arteriovenous difference in plasma lipids across the mammary gland.(ABSTRACT TRUNCATED AT 250 WORDS)

Animal Feed↗